Find your path to Johnny
1,249 people in our graph share verified history with Johnny — schools, employers, funds. One of them is your warm intro.
Yaryna NychunlockedJohnny: together at Harvard University (2016–2017)
×2Johnny: together at Harvard University
×8Johnny: together at Menlo Ventures
Johnny: together at University of Cambridge
About
Johnny Hu is a principal at Menlo Ventures who invests in biotech and life science companies, focusing on novel therapeutics and new medical technologies at the earliest stages. Before Menlo, he was a vice president at Longitude Capital and previously an associate at Omega Funds, and during his Ph.D. he contributed to gene editing technologies later licensed by companies including Editas Medicine and Beam Therapeutics. He holds a Ph.D. and an A.B. in Chemical and Physical Biology from Harvard University, and an M.Phil. from the University of Cambridge, where he was a Gates Cambridge Scholar.
Invests in
AI & Machine LearningBiotechCybersecurityFintechHealthtech
Experience
- VilyaBoard Membercurrent2024 — present
- Menlo VenturesPrincipalcurrent2021 — presentSan Francisco Bay Area
- Endeavor BiomedicinesBoard Observer2020 — 2021
- LEXEO TherapeuticsBoard Observer2020 — 2021
- Longitude CapitalVice President2019 — 2021Greater Boston
- Omega FundsAssociate2018 — 2019Greater Boston
- Vida Ventures, LLCFellow2017 — 2018Greater Boston
- The Biotech Connection at BostonPresident2015 — 2017
- PureTech HealthIntern2017Greater Boston
- RA Capital Management, LLCAssociate Intern2015Greater Boston
- GenentechResearch Oncology2011
- Howard Hughes Medical InstituteJanelia Farm Undergraduate Research Scholar2009
Skills & more
PCR7Cell Culture12Biochemistry12Lifesciences3Molecular Biology15Cell Biology8Protein Purification5Fluorescence Microscopy2DNA1Genetics4Molecular Cloning3Immunohistochemistry1
+8 more
Flow CytometryGel ElectrophoresisProtein ExpressionWestern BlottingStem CellsLife SciencesPolymerase Chain Reaction (PCR)ResearchFrom Johnny's professional profile.
Investments
Board seats
Endeavor BiomedicinesLexeo TherapeuticsOpna IO
Per the firm's website.
Colleagues at Menlo Ventures
Amy Wu
General Partner at Menlo Ventures
Amy Wu Martin
Partner at Menlo Ventures
Andrew Hsu
Founder at Speak
Brent Fellows
Vice President, Finance and Tax at Menlo Ventures
Bryan Eglan
Director of Business Development at Menlo Ventures
C.C. Gong
Principal at Menlo Ventures
Carolan Shawn
General Partner at Menlo Ventures
Claire Palmer
Director of Investor Relations at Menlo Ventures
Network1
Investors connected to Johnny in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Johnny Hu?
- Johnny Hu is a principal at Menlo Ventures who invests in biotech and life science companies, focusing on novel therapeutics and new medical technologies at the earliest stages. Before Menlo, he was a vice president at Longitude Capital and previously an associate at Omega Funds, and during his Ph.D. he contributed to gene editing technologies later licensed by companies including Editas Medicine and Beam Therapeutics. He holds a Ph.D. and an A.B. in Chemical and Physical Biology from Harvard University, and an M.Phil. from the University of Cambridge, where he was a Gates Cambridge Scholar.
- Where does Johnny Hu work?
- Johnny Hu is Principal at Menlo Ventures.
- What does Johnny Hu invest in?
- Johnny Hu invests in AI & Machine Learning, Biotech, Cybersecurity, Fintech, Healthtech.
- What check size does Johnny Hu write?
- Johnny Hu typically writes checks of $250K – $15M.
- What boards does Johnny Hu sit on?
- Johnny Hu holds tracked board seats at Endeavor Biomedicines, Lexeo Therapeutics, Opna IO.
- Where did Johnny Hu go to school?
- Johnny Hu studied at Harvard University (Doctor of Philosophy (PhD), Biological and Biomedical Sciences); University of Cambridge (MPhil, Biological Sciences); Harvard University (Bachelor of Arts, Chemical and Physical Biology, Economics Secondary).
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended University of Cambridge1,413
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 1,407 more
Shared employers
Also worked at Endeavor Biomedicines10
Monal MehtaVenture Partner at Versant VenturesPatrick EnrightManaging Director at Longitude CapitalCindy WangVice President at Longitude CapitalNoelle HutchinsSenior Associate at Omega FundsSandip AgarwalaManaging Director at Blue Owl CapitalJohn HoodDirector, Executive Officer at Endeavor Biomedicines
+ 4 more
Also worked at Longitude Capital48
Ms. BakkerManaging Director and Founder at Longitude CapitalMs. HelmsManaging Director and Chief Financial Officer at Longitude CapitalJeff JonsonDirector of IT at Longitude CapitalDenise KnoppingVP of People at Longitude CapitalCristiana OliveiraHead of Legal and Chief Compliance Officer at Longitude CapitalErin WrightExecutive Assistant at Longitude Capital
+ 42 more
Also worked at Omega Funds21
Nessan BerminghamInvestor at Khosla VenturesLiam FlahertyInvestor at Silversmith Capital PartnersRichard LimManaging Partner at Cure VenturesAnnie MitsakPartner at Cure VenturesJohn MaraganoreAdvisor at Oak HC/FTWalter StockingerManaging Partner at Hadean Ventures
+ 15 more
